Ulysses Neuroscience

Ulysses Neuroscience Ltd is a rapidly growing translational CRO accelerating drug discovery across CNS therapeutic areas, including depression, psychedelics, and neuropsychiatric, neurodegenerative and rare neurodevelopmental disorders. We operate through two integrated divisions—Preclinical Neuropharmacology and Translational Medicine—delivering one seamless, biomarker-driven pipeline from discovery to early clinical development.

Our platforms combine validated behavioral assays, EEG, molecular biomarkers, human iPSC-derived neurons, and advanced in vivo models, all under one roof. With facilities in Ireland and access to well-characterised patient populations, we apply a strongly patient-centric approach to generate robust, clinically relevant data and de-risk CNS drug development.

Website: www.ulysses-neuro.com